COMPASS Pathways plc financial data

Symbol
CMPS on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Rd Floor, 1 Ashley Road, Altrincham, Chesire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Compass Rx Ltd. (to 8/10/2020)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.54 K % +32.5%
Debt-to-equity 20.9 % +122%
Return On Equity -57.2 % -15.4%
Return On Assets -47.3 % -4.37%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.4 M shares +59.9%
Common Stock, Shares, Outstanding 68.3 M shares
Entity Public Float 216 M USD -12.7%
Common Stock, Value, Issued 699 K USD
Weighted Average Number of Shares Outstanding, Basic 64.2 M shares +50.3%
Weighted Average Number of Shares Outstanding, Diluted 64.2 M shares +50.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 93.4 M USD +35.9%
General and Administrative Expense 50.3 M USD +4.74%
Operating Income (Loss) -144 M USD -23.1%
Nonoperating Income (Expense) 15.1 M USD -33.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -129 M USD -36.6%
Income Tax Expense (Benefit) 872 K USD +119%
Net Income (Loss) Attributable to Parent -129 M USD -36.9%
Earnings Per Share, Basic -2.3 USD/shares -3.14%
Earnings Per Share, Diluted -2.3 USD/shares -3.14%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 263 M USD +124%
Other Assets, Current 1.72 M USD +15.4%
Assets, Current 296 M USD +76.1%
Deferred Income Tax Assets, Net 3.66 M USD +40.8%
Property, Plant and Equipment, Net 359 K USD -41.3%
Operating Lease, Right-of-Use Asset 3.72 M USD +134%
Other Assets, Noncurrent 6.1 M USD +2776%
Assets 309 M USD +78.3%
Accounts Payable, Current 9.34 M USD +141%
Employee-related Liabilities, Current 3.12 M USD +4.81%
Liabilities, Current 19.4 M USD +72.4%
Operating Lease, Liability, Noncurrent 1.34 M USD +225%
Liabilities 49.8 M USD +327%
Accumulated Other Comprehensive Income (Loss), Net of Tax -17 M USD +2.77%
Retained Earnings (Accumulated Deficit) -415 M USD -45.4%
Stockholders' Equity Attributable to Parent 259 M USD +60.3%
Liabilities and Equity 309 M USD +78.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.8 M USD +24.9%
Net Cash Provided by (Used in) Financing Activities 63.5 M USD +5786%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 68.3 M shares
Common Stock, Shares, Issued 68.3 M shares
Common Stock, Par or Stated Value Per Share 0.01 GBP/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 42.6 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 263 M USD +124%
Interest Paid, Excluding Capitalized Interest, Operating Activities 765 K USD
Deferred Tax Assets, Valuation Allowance 76.1 M USD +46.5%
Deferred Tax Assets, Gross 79.5 M USD +46.5%
Operating Lease, Liability 3.72 M USD +144%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -129 M USD -13.5%
Lessee, Operating Lease, Liability, to be Paid 3.99 M USD +148%
Property, Plant and Equipment, Gross 1.15 M USD +51.7%
Operating Lease, Liability, Current 2.38 M USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year Two 227 K USD +1.79%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.81 M USD +568%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +33.3%
Deferred Income Tax Expense (Benefit) -1.11 M USD +23.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 274 K USD +230%
Lessee, Operating Lease, Liability, to be Paid, Year Three 96 K USD +74.5%
Deferred Tax Assets, Operating Loss Carryforwards 64.7 M USD +46.4%
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 1.89 M USD +1.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95 K USD +75.9%
Operating Lease, Payments 628 K USD +11.7%
Additional Paid in Capital 690 M USD +48.8%
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 61 K USD +27.1%
Share-based Payment Arrangement, Expense 18.3 M USD +30.4%
Interest Expense 1.1 M USD